Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Direct multiplexed measurement of gene expression with color-coded probe pairs.

Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, Fell HP, Ferree S, George RD, Grogan T, James JJ, Maysuria M, Mitton JD, Oliveri P, Osborn JL, Peng T, Ratcliffe AL, Webster PJ, Davidson EH, Hood L, Dimitrov K.

Nat Biotechnol. 2008 Mar;26(3):317-25. doi: 10.1038/nbt1385. Epub 2008 Feb 17.

PMID:
18278033
2.

Construction, expression, and characterization of anticarcinoma sFv fused to IL-2 or GM-CSF.

Zhao L, Rai SK, Grosmaire LS, Ledbetter JA, Fell HP.

J Hematother Stem Cell Res. 1999 Aug;8(4):393-9.

PMID:
10634177
3.
4.

Role of epidermal growth factor receptor family members in growth and differentiation of breast carcinoma.

Cohen BD, Siegall CB, Bacus S, Foy L, Green JM, Hellström I, Hellström KE, Fell HP.

Biochem Soc Symp. 1998;63:199-210. Review.

PMID:
9513724
5.

Expression and characterization of bryodin 1 and a bryodin 1-based single-chain immunotoxin from tobacco cell culture.

Francisco JA, Gawlak SL, Miller M, Bathe J, Russell D, Chace D, Mixan B, Zhao L, Fell HP, Siegall CB.

Bioconjug Chem. 1997 Sep-Oct;8(5):708-13.

PMID:
9327135
6.

The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells.

Cohen BD, Kiener PA, Green JM, Foy L, Fell HP, Zhang K.

J Biol Chem. 1996 Nov 29;271(48):30897-903.

7.

Surface expression of CD28 single chain Fv for costimulation by tumor cells.

Winberg G, Grosmaire LS, Klussman K, Hayden MS, Fell HP, Ledbetter JA, Mittler RS.

Immunol Rev. 1996 Oct;153:209-23. Review. No abstract available.

PMID:
9010725
8.

Costimulation by CD28 sFv expressed on the tumor cell surface or as a soluble bispecific molecule targeted to the L6 carcinoma antigen.

Hayden MS, Grosmaire LS, Norris NA, Gilliland LK, Winberg G, Tritschler D, Tsu TT, Linsley PS, Mittler RS, Senter PD, Fell HP, Ledbetter JA.

Tissue Antigens. 1996 Oct;48(4 Pt 1):242-54.

PMID:
8946677
9.
10.
11.

Bacterial aspects associated with the expression of a single-chain antibody fragment in Escherichia coli.

Somerville JE Jr, Goshorn SC, Fell HP, Darveau RP.

Appl Microbiol Biotechnol. 1994 Dec;42(4):595-603.

PMID:
7765735
12.

Prevention of immunotoxin-mediated vascular leak syndrome in rats with retention of antitumor activity.

Siegall CB, Liggitt D, Chace D, Tepper MA, Fell HP.

Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9514-8.

13.

Structure-activity analysis of the antitumor and hemolytic properties of the amphiphilic alpha-helical peptide, C18G.

Peck-Miller KA, Blake J, Cosand WL, Darveau RP, Fell HP.

Int J Pept Protein Res. 1994 Aug;44(2):143-51.

PMID:
7982758
14.
15.

Single-chain mono- and bispecific antibody derivatives with novel biological properties and antitumour activity from a COS cell transient expression system.

Hayden MS, Linsley PS, Gayle MA, Bajorath J, Brady WA, Norris NA, Fell HP, Ledbetter JA, Gilliland LK.

Ther Immunol. 1994 Jan;1(1):3-15.

PMID:
7584477
16.

Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions.

Calderhead DM, Buhlmann JE, van den Eertwegh AJ, Claassen E, Noelle RJ, Fell HP.

J Immunol. 1993 Nov 15;151(10):5261-71.

PMID:
8228223
17.

Genetic construction, expression, and characterization of a single chain anti-carcinoma antibody fused to beta-lactamase.

Goshorn SC, Svensson HP, Kerr DE, Somerville JE, Senter PD, Fell HP.

Cancer Res. 1993 May 1;53(9):2123-7.

18.

Identification of serum components that inhibit the tumoricidal activity of amphiphilic alpha helical peptides.

Peck-Miller KA, Darveau RP, Fell HP.

Cancer Chemother Pharmacol. 1993;32(2):109-15.

PMID:
8485805
20.

Chimeric L6 anti-tumor antibody. Genomic construction, expression, and characterization of the antigen binding site.

Fell HP, Gayle MA, Yelton D, Lipsich L, Schieven GL, Marken JS, Aruffo A, Hellström KE, Hellström I, Bajorath J.

J Biol Chem. 1992 Aug 5;267(22):15552-8.

21.

Role of contact and soluble factors in the growth and differentiation of B cells by helper T cells.

Noelle RJ, Marshall L, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo A, Fell HP.

Adv Exp Med Biol. 1992;323:131-8. Review. No abstract available.

PMID:
1283047
22.
23.
24.

Epitope mapping and use of anti-idiotypic antibodies to the L6 monoclonal anticarcinoma antibody.

Hellström KE, Yelton DE, Fell HP, Beaton D, Gayle M, MacLean M, Kahn M, Hellström I.

Cancer Res. 1990 Apr 15;50(8):2449-54.

25.

Homologous recombination in hybridoma cells: heavy chain chimeric antibody produced by gene targeting.

Fell HP, Yarnold S, Hellström I, Hellström KE, Folger KR.

Proc Natl Acad Sci U S A. 1989 Nov;86(21):8507-11.

26.

Reciprocal product of a t(12;15) in murine plasmacytoma TEPC 1033:5' c-myc to IgH enhancer region.

Gilliam AC, Fell HP, Carayannopuolos L, Tucker PW.

Nucleic Acids Res. 1989 Sep 25;17(18):7533. No abstract available.

27.

Immunoglobulin genes.

Fell HP, Tucker PW.

Immunol Ser. 1989;43:181-202. Review. No abstract available.

PMID:
2490496
28.

Regional localization of the human c-rel locus using translocation chromosome analysis.

Brownell E, Fell HP, Tucker PW, Geurts van Kessel AH, Hagemeijer A, Rice NR.

Oncogene. 1988 May;2(5):527-9.

PMID:
3287280
29.

An immunoglobulin light chain dimer with CD4 antigen specificity.

Ledbetter JA, Fell HP, Grosmaire LS, Norris NA, Tsu TT.

Mol Immunol. 1987 Dec;24(12):1255-61.

PMID:
2448606
30.

Molecular analysis of the t(2;14) translocation of childhood chronic lymphocytic leukemia.

Fell HP, Smith RG, Tucker PW.

Science. 1986 Apr 25;232(4749):491-4.

PMID:
3961491

Supplemental Content

Support Center